Remote daily real-time monitoring in patients with COPD - A feasibility study using a novel device

Respiratory Medicine

Volumn 103, Issue 9, 2009, Pages 1320-1328

  Sund, Z M ^a   Powell, T ^a   Greenwood, R ^a   Jarad, N A ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Acute exacerbations of chronic obstructive pulmonary disease (AECOPD); Chronic obstructive pulmonary disease (COPD); Daily electronic monitoring

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE EXACERBATION; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; MALE; PATIENT MONITORING; PORTABLE EQUIPMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM; SPIROMETER; SPIROMETRY; SYMPTOM;

AGED; FEASIBILITY STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMANS; MALE; MONITORING, AMBULATORY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 68149136739     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.03.017     Document Type: Article

References (28)

1. Jadwiga A., Wedzicha A., and Wilkinson T. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers. Proc Am Thorac Soc 3 (2006) 218-221
2. Spencer S., Calverley P.M.A., Burge P.S., and Jones P.W. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 23 (2004) 698-702
3. O'Reilly J.F., Williams A.E., and Rice L. Health status impairment and costs associated with COPD exacerbation managed in hospital. Int J Clin Pract 61 (2007) 1112-1120
4. Seemungal T.A.R., Donaldson G.C., Paul E.A., Bestall J.C., Jeffries J.D., and Wedzicha J.A. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157 (1998) 1418-1422
5. Donaldson G.C., Seemungal T.A., Bhowmik A., and Wedzicha J.A. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57 (2002) 847-852
6. Anthonisen N.R., Manfreda K.J., Warren C.P., Hershfield E.S., Harding G.K., and Nelson N.A. Antibiotic therapy in exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 106 2 (1987) 196-204
7. Donaldson G.C., and Wedzicha J.A. COPD exacerbations. 1: Epidemiology. Thorax 61 (2006) 164-168
8. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152 (1995) S77-S120
9. Celli B.R., MacNee W., Agusti A., Anzueto A., Berg B., Buist A.S., et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position. Eur Respir J 23 (2004) 932-946
10. Rodriguez-Roison R. Towards a consensus definition for COPD exacerbation. Chest 117 (2000) 398S-401S
11. Burge S., and Wedzicha J.A. COPD exacerbations: definitions and classifications. Eur Respir J 21 (2003) 46S-53S
12. Seemungal T.A.R., Donaldson G.C., Bhowmik A., Jefferies D.J., and Wedzicha J.A. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161 (2000) 1608-1613
13. Wilkinson T.M., Donaldson G.C., Hurst J.R., Seemungal T.A., and Wedzicha J.A. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 169 (2004) 1298-1303
14. Wedzicha J.A., Calverley P.M.A., Seemungal T.A., Hagan G., Ansari Z., and Stockley R.A. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 177 (2008) 19-26
15. Gadoury M.A., Schwartzman K., Rouleau M., Maltais F., Julien M., Beaupré A., et al. Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J 26 (2005) 853-857
16. Kida K., Katsura H., Yamada K., Motegi T., and Mizuno S. Guided self-care using daily recording of peak expiratory flow and diary description for chronic airway obstruction in the elderly. Geriatr Gerontol Int 1 (2001) 18-24
17. Jones P., and Higenbottam T. Quantifying of severity of exacerbations in chronic obstructive pulmonary disease. Adaptations to the definition to allow quantification. Proc Am Thorac Soc 4 (2007) 597-601
18. Sarfaraz S., and Jarad N.A. The use of mobile technologies in early detection of pulmonary exacerbation of CF, time to be precise [abstract]. J Cyst Fibros 4 Suppl. 1 (2005) PS61
19. Medical research council questionnaire on respiratory symptoms; 1976.
20. British Thoracic Society and the Association of Respiratory Technicians and Physiologists. Guidelines for the measurement of respiratory function. Respir Med 88 (1994) 165-194
21. Hajiro T., Nishimura K., Jones P.W., Tsukino M., Ikeda A., Koyama H., et al. A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 1874-1878
22. BTS/NICE. National clinical guideline on management of chronic obstructive pulmonary disease in adults and primary and secondary care. Thorax 59 Suppl. I (2004). http://www.nice.nhs.uk www.nice.nhs.uk
23. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1618-1623
24. Tashkin D.P., Celli B., Senn S., Bukhart D., Kesten S., Menjoge S., et al., the UPLIFT Study Investigators. A 4 year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359 (2008) 1543-1554
25. Wouters E.F. Economic analysis of the confronting COPD survey: an over of results. Respir Med 97 Suppl. C (2003) S3-S14
26. Sridhar M., Taylor R., Dawson S., Roberts N.J., and Partridge M.R. A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive airway disease. Thorax 63 (2008) 194-200
27. Burge P.S., Calverley P.M.A., Jones P.W., Spencer S., Anderson J.A., and Maslen T.K. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease; the ISOLDE trial. BMJ 320 (2000) 1297-1303
28. Calverley P.M.A., Anderson J.A., Celli B., Ferguson G.T., Jenkins C., Jones P.W., et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356 (2007) 775-789